Literature DB >> 22983916

Function and dysfunction of α-synuclein: probing conformational changes and aggregation by single molecule fluorescence.

Adam J Trexler1, Elizabeth Rhoades.   

Abstract

The aggregation and deposition of the neuronal protein α-synuclein in the substantia nigra region of the brain is a key pathological feature of Parkinson's disease. α-Synuclein assembles from a monomeric state in solution, which lacks stable secondary and tertiary contacts, into highly structured fibrillar aggregates through a pathway which involves the population of multiple oligomeric species over a range of time scales. These features make α-synuclein well suited for study with single-molecule techniques, which are particularly useful for characterizing dynamic, heterogeneous samples. Here, we review the current literature featuring single-molecule fluorescence studies of α-synuclein and discuss how these studies have contributed to our understanding of both its function and its role in disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22983916      PMCID: PMC3552099          DOI: 10.1007/s12035-012-8338-x

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  94 in total

1.  Single-molecule FRET reveals structural heterogeneity of SDS-bound alpha-synuclein.

Authors:  Gertjan Veldhuis; Ine Segers-Nolten; Eva Ferlemann; Vinod Subramaniam
Journal:  Chembiochem       Date:  2009-02-13       Impact factor: 3.164

2.  Early stages for Parkinson's development: alpha-synuclein misfolding and aggregation.

Authors:  Junping Yu; Yuri L Lyubchenko
Journal:  J Neuroimmune Pharmacol       Date:  2008-07-17       Impact factor: 4.147

3.  Simulation studies on the stabilities of aggregates formed by fibril-forming segments of alpha-Synuclein.

Authors:  Jeseong Yoon; Soonmin Jang; Kyunghee Lee; Seokmin Shin
Journal:  J Biomol Struct Dyn       Date:  2009-12

4.  Interplay of alpha-synuclein binding and conformational switching probed by single-molecule fluorescence.

Authors:  Allan Chris M Ferreon; Yann Gambin; Edward A Lemke; Ashok A Deniz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-17       Impact factor: 11.205

5.  Structure-neurotoxicity relationships of amyloid beta-protein oligomers.

Authors:  Kenjiro Ono; Margaret M Condron; David B Teplow
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-12       Impact factor: 11.205

6.  Annular protofibrils are a structurally and functionally distinct type of amyloid oligomer.

Authors:  Rakez Kayed; Anna Pensalfini; Larry Margol; Yuri Sokolov; Floyd Sarsoza; Elizabeth Head; James Hall; Charles Glabe
Journal:  J Biol Chem       Date:  2008-12-18       Impact factor: 5.157

7.  At low concentrations, 3,4-dihydroxyphenylacetic acid (DOPAC) binds non-covalently to alpha-synuclein and prevents its fibrillation.

Authors:  Wenbo Zhou; Amy Gallagher; Dong-Pyo Hong; Chunmei Long; Anthony L Fink; Vladimir N Uversky
Journal:  J Mol Biol       Date:  2009-03-25       Impact factor: 5.469

8.  Dopamine and the dopamine oxidation product 5,6-dihydroxylindole promote distinct on-pathway and off-pathway aggregation of alpha-synuclein in a pH-dependent manner.

Authors:  Chi L L Pham; Su Ling Leong; Feda E Ali; Vijaya B Kenche; Andrew F Hill; Sally L Gras; Kevin J Barnham; Roberto Cappai
Journal:  J Mol Biol       Date:  2009-02-11       Impact factor: 5.469

9.  Converse modulation of toxic alpha-synuclein oligomers in living cells by N'-benzylidene-benzohydrazide derivates and ferric iron.

Authors:  Andreas S Hillmer; Preeti Putcha; Johannes Levin; Tobias Högen; Bradley T Hyman; Hans Kretzschmar; Pamela J McLean; Armin Giese
Journal:  Biochem Biophys Res Commun       Date:  2009-11-13       Impact factor: 3.575

10.  Differential phospholipid binding of alpha-synuclein variants implicated in Parkinson's disease revealed by solution NMR spectroscopy.

Authors:  Christina R Bodner; Alexander S Maltsev; Christopher M Dobson; Ad Bax
Journal:  Biochemistry       Date:  2010-02-09       Impact factor: 3.162

View more
  7 in total

1.  Comparison of strategies for non-perturbing labeling of α-synuclein to study amyloidogenesis.

Authors:  Conor M Haney; Rebecca F Wissner; John B Warner; Yanxin J Wang; John J Ferrie; Dustin J Covell; Richard J Karpowicz; Virginia M-Y Lee; E James Petersson
Journal:  Org Biomol Chem       Date:  2016-02-07       Impact factor: 3.876

2.  Transient β-hairpin formation in α-synuclein monomer revealed by coarse-grained molecular dynamics simulation.

Authors:  Hang Yu; Wei Han; Wen Ma; Klaus Schulten
Journal:  J Chem Phys       Date:  2015-12-28       Impact factor: 3.488

Review 3.  Targeting the chameleon: a focused look at α-synuclein and its roles in neurodegeneration.

Authors:  Blanca A Silva; Leonid Breydo; Vladimir N Uversky
Journal:  Mol Neurobiol       Date:  2012-09-01       Impact factor: 5.590

4.  Effect of an Amyloidogenic SARS-COV-2 Protein Fragment on α-Synuclein Monomers and Fibrils.

Authors:  Asis K Jana; Chance W Lander; Andrew D Chesney; Ulrich H E Hansmann
Journal:  J Phys Chem B       Date:  2022-05-17       Impact factor: 3.466

Review 5.  Alpha-synuclein function and dysfunction on cellular membranes.

Authors:  David Snead; David Eliezer
Journal:  Exp Neurobiol       Date:  2014-12-12       Impact factor: 3.261

Review 6.  α-synuclein in the pathophysiology of Alzheimer's disease.

Authors:  Daniel Twohig; Henrietta M Nielsen
Journal:  Mol Neurodegener       Date:  2019-06-11       Impact factor: 14.195

7.  Small Molecule Sequestration of the Intrinsically Disordered Protein, p27Kip1, Within Soluble Oligomers.

Authors:  Luigi I Iconaru; Sourav Das; Amanda Nourse; Anang A Shelat; Jian Zuo; Richard W Kriwacki
Journal:  J Mol Biol       Date:  2021-06-29       Impact factor: 6.151

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.